Infections and solid organ transplant rejection: a cause-and-effect relationship?
- 1 September 2002
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (9) , 539-549
- https://doi.org/10.1016/s1473-3099(02)00370-5
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- CYTOMEGALOVIRUS ANTIGENEMIA DIRECTED PRE-EMPTIVE PROPHYLAXIS WITH ORAL VERSUS I.V. GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1Transplantation, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver TransplantationThe Journal of Infectious Diseases, 1995
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal TransplantationNew England Journal of Medicine, 1983
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal AllograftsNew England Journal of Medicine, 1981
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979
- Viral Infection and Renal Transplant RejectionBMJ, 1972